Search
forResearch 10 of 1000+
- Ixekizumab improves physical function, quality of life, and work productivity in biologic disease-modifying antirheumatic drug-naive patients with active psoriatic arthritis
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- Adverse Effects and Drug Interactions of Biologic Agents
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Biologic: A Double Edged Sword - A Case of Etanercept Induced Alopecia Areata in a Patient with Psoriasis Vulgaris
- Development of Novel Drug Delivery Systems for the Treatment of Alopecia
- Safety concerns of paternal drug exposure on fertility, pregnancy and offspring: An analysis based on the FDA adverse event reporting system
- Plasma proteome–driven identification of druggable immune regulators of alopecia areata, validated by transcriptome and single-cell mapping
- Grand challenges in dermatologic drug discovery: four priorities to transform skin disease treatment
- Advances in the treatment of autosomal recessive congenital ichthyosis, a look towards the repositioning of drugs
Community 2 of 4
- HMI-115 update: Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia
- Why hasn’t anyone made a "DHT sponge" biologic yet???